Today's Top Health News Story

U.S. advisory panel to review rare clot risk with J&J COVID-19 vaccine after its use was paused

WASHINGTON (Reuters) -A U.S. health advisory panel on Wednesday will review six reported cases of rare blood clots in women who received Johnson & Johnson's COVID-19 vaccine a day after federal regulators paused its use to assess the issue. Learn More


More Top Health Stories

Fauci says pause on J&J COVID-19 shot should not prompt vaccine hesitancy

(Reuters) - Top U.S. health officials urged Americans to get vaccinated against COVID-19 on Wednesday, saying U.S. regulators' pause on Johnson & Johnson shots, following reports it can cause blood clotting, should boost confidence in the vaccines' safety. More »


U.S. administers 194.8 million doses of COVID-19 vaccines: CDC

The United States had administered 194,791,836 doses of COVID-19 vaccines in the country as of Wednesday morning and distributed 250,998,265 doses, the U.S. Centers for Disease Control and Prevention said on Wednesday. More »


Empty middle airplane seat could cut coronavirus exposure by up to 57%: CDC

(Reuters) - A vacant middle airplane seat could cut the risk of exposure to coronavirus by 23% to 57% compared with a full flight, according to a study on physical distancing onboard released on Wednesday. More »


Moderna vaccines promising vs variants in mouse study; no higher risk for poor outcomes found with UK variant

(Reuters) -The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. More »


Europe's vaccine rollout hit by doubts over J&J, AstraZeneca shots

COPENHAGEN (Reuters) -Europe's choppy vaccine rollout hit more trouble on Wednesday after U.S. drugmaker Johnson & Johnson delayed its COVID-19 shot and Denmark said it would drop a similar vaccine from AstraZeneca over the risk of blood clotting. More »


Moderna COVID-19 shot production unlikely to rise significantly in next few months - CEO

NEW YORK (Reuters) -The pace of Moderna Inc's COVID-19 vaccine production is unlikely to speed up markedly in the next few months, though the U.S. drugmaker expects output to have increased significantly by 2022, its chief executive said on Wednesday. More »


Healthcare collapse imminent, Brazil's Sao Paulo warns, as COVID-19 cases surge

SAO PAULO/BRASILIA (Reuters) - Brazil's richest and most populous state, Sao Paulo, has warned its ability to care for seriously ill COVID-19 patients was on the verge of collapse as it ran perilously low on key drugs, according to a letter to the federal government seen by the Folha de Sao Paulo newspaper. More »


Americas not behaving as if in midst of worsening COVID-19 crisis -regional health official warns

BOGOTA (Reuters) -The Americas are not behaving like a region experiencing an ever-graver outbreak of COVID-19, the director of the Pan American Health Organization (PAHO) warned on Wednesday. More »


France's COVID-19 infection cases accelerate, hospital pressure eases slightly

PARIS (Reuters) - France saw a decline in the number of COVID patients in intensive care units on Wednesday, and the daily death toll fell, but the number of new infections continued to grow. More »


News, Photo and Web Search